CME Group Inc. (CME) vs Invesco S&P 500 Equal Weight ETF (RSP)
Over the past 10 years, CME outperformed RSP — 14.23% vs 11.91% annualized total return (price plus dividends).
A side-by-side comparison of CME Group Inc. and Invesco S&P 500 Equal Weight ETF across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 1, 2026. Differences are shown without an overall score or investment verdict.
Total return — CME vs RSP
growth of $100 · dividends reinvested · last 10yMetrics side by side
Did CME beat RSP?
Over the past 10 years, CME outperformed RSP — 14.23% vs 11.91% annualized total return (price plus dividends).
Total return (annualized)
| Metric | CME | RSP |
|---|---|---|
| Total return (1Y) | 8.64% | 17.13% |
| Total return CAGR (3Y) | 16.08% | 14.92% |
| Total return CAGR (5Y) | 11.26% | 8.63% |
| Total return CAGR (10Y) | 14.23% | 11.91% |
RSP is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has CME beaten RSP?
- Over the past 10 years, CME outperformed RSP — 14.23% vs 11.91% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 1, 2026.